Latest Articles

Publication Date
Karen Nyamu speech overpowered by 'Wantam' chants during endometriosis event - TNX Africa

Karen Nyamu speech overpowered by 'Wantam' chants during endometriosis event TNX Africa

Published: Sept. 28, 2026, 8:19 a.m.
Karen Nyamu speech overpowered by 'Wantam' chants during endometriosis event - standardmedia.co.ke

Karen Nyamu speech overpowered by 'Wantam' chants during endometriosis event standardmedia.co.ke

Published: Sept. 28, 2026, 8:19 a.m.
Karen Nyamu speech overpowered by 'Wantam' chants during endometriosis event - tnx.africa

Karen Nyamu speech overpowered by 'Wantam' chants during endometriosis event tnx.africa

Published: Sept. 28, 2026, 8:19 a.m.
Nyamu: I expected ‘Wantam’ chants at endometriosis event - the-star.co.ke

Nyamu: I expected ‘Wantam’ chants at endometriosis event the-star.co.ke

Published: Sept. 28, 2026, 6:46 a.m.
"Watanipeleka wapi?": Nyamu dances to Siaka song after being heckled at KICC - Tuko News

"Watanipeleka wapi?": Nyamu dances to Siaka song after being heckled at KICC Tuko News

Published: Sept. 28, 2026, 6:44 a.m.
"Watanipeleka wapi?": Nyamu dances to Siaka song after being heckled at KICC - tuko.co.ke

"Watanipeleka wapi?": Nyamu dances to Siaka song after being heckled at KICC tuko.co.ke

Published: Sept. 28, 2026, 6:44 a.m.
Guggenheim reiterates Absci stock rating on endometriosis trial delay - Investing.com

Guggenheim reiterates Absci stock rating on endometriosis trial delay Investing.com

Published: Sept. 28, 2026, 6:43 a.m.
Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com - Investing.com Canada

Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com Investing.com Canada

Published: Sept. 28, 2026, 6:35 a.m.
Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com - Investing.com Nigeria

Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com Investing.com Nigeria

Published: Sept. 28, 2026, 6:34 a.m.
Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com - Investing.com India

Guggenheim reiterates Absci stock rating on endometriosis trial delay By Investing.com Investing.com India

Published: Sept. 28, 2026, 6:25 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!